Next Article in Journal
Four Cycles of Docetaxel-Cyclophosphamide versus Anthracycline-Taxane as Adjuvant Chemotherapy for HER2-Negative, Axillary Lymph Node Negative Breast Cancer: A Real-World Comparison of Alberta Patients Treated 2008–2012
Previous Article in Journal
An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation or Maintenance Systemic Therapy for Newly Diagnosed Stage II, III, or IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma
 
 
Article

Article Versions Notes

Curr. Oncol. 2021, 28(2), 1125-1136; https://doi.org/10.3390/curroncol28020108
Action Date Notes Link
article xml file uploaded 2 March 2021 14:25 CET Original file -
article xml uploaded. 2 March 2021 14:25 CET Update https://www.mdpi.com/1718-7729/28/2/108/xml
article pdf uploaded. 2 March 2021 14:25 CET Version of Record https://www.mdpi.com/1718-7729/28/2/108/pdf
article supplementary file uploaded. 2 March 2021 14:25 CET - https://www.mdpi.com/1718-7729/28/2/108#supplementary
article html file updated 2 March 2021 14:26 CET Original file -
article html file updated 25 July 2022 05:47 CEST Update https://www.mdpi.com/1718-7729/28/2/108/html
Back to TopTop